Age-related changes in interferon-α/β receptor expression, binding, and induction of apoptosis in natural killer cells from C57BL/6 mice

Mechanisms of Ageing and Development

Volumn 118, Issue 3, 2000, Pages 129-144

  Plett, P Artur ^a   Gardner, Elizabeth M ^a   Murasko, Donna M ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Aging; Apoptosis; Interferon ; Mice; NK cells

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; FAS ANTIGEN; INTERFERON RECEPTOR;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL STIMULATION; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; TUMOR GROWTH; VIRUS INFECTION;

AGING; ANIMAL; ANTIGENS, CD95; APOPTOSIS; CYTOTOXICITY, IMMUNOLOGIC; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; PROTEIN BINDING; RECEPTORS, INTERFERON; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0034730901     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(00)00164-0     Document Type: Article

References (34)

1. Albright J.W., Albright J.F. Age-associated impairment of murine natural killer activity. Proc. Natl. Acad. Sci. USA. 80:1983;6371-6375.
2. Alderson M.R., Armitage R.J., Maraskovsky E., Tough T.W., Roux E., Schooley K., Ramsdell F, Lynch D.H. Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178:1993;2231-2235.
3. Chow S.C., Weiss M., Kass G.E.N., Holmstrom T.H., Eriksson J.E., Orrenius S. Involvement of multiple proteases during Fas-mediated apoptosis in T lymphocytes. FEBS Lett. 364:1995;134-138.
4. Coligan J.E., Krisbeek A.M., Margulies D.H., Shevach E.M. Zola H. Current Protocols in Immunology. 1998;1-16 Wiley, New York.
5. Eischen C.M., Schilling J.D., Lynch D.H., Krammer P.H., Leibson P.J. Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis. J. Immunol. 156:1996;2693-2699.
6. Eischen C.M., Leibson P.J. Role for NK-cell-associated Fas ligand in cell-mediated cytotoxicity and apoptosis. 69th Forum Immunol. 11:1997;164-169.
7. Fleischmann W.R., Fleischmann C.M. Mechanisms of interferons' antitumor actions. Baron S., Coppenhaveret D.H. Interferon: Principles and Medical Applications. 1992;299-310 Galveston, TX, University of Texas Medical Branch at Galveston.
8. Ghislain J., Lingwood C.A., Fish E. Evidence for glycoshingolipid modification of the type I IFN receptor. J. Immunol. 153:1994;3655-3663.
9. Hobbs M.V., Weigle W.O., Noonan D.J., Torbett B.E., McEvilly R.J., Koch R.J., Cardnas G.J., Ernst D.N. Patterns of cytokine gene expression by CD4+ T cells from young and old mice. J. Immunol. 150:1993;3602-3614.
10. Hunter C.A., Gabriel K.E., Radzanowski T., Neyer L.E., Remington J.S. Type I interferons enhance production of IFN-γ by NK cells. Immunol. Lett. 59:1997;1-5.
11. Jewett A., Bonavida B. Target-induced anergy of natural killer cytotoxic function is restricted to the NK-target conjugate subset. Cell Immunol. 160:1995;91-97.
12. Kiessling R., Petranyi G., Klein G., Wigzell H. Genetic variation of in vitro cytolytic activity and in vivo rejection potential of nonimmunized semisyngeneic mice against a mouse lymphoma line. Int. J. Cancer. 15:1975;933-940.
13. Kutza J., Murasko D.M. Effects of aging on natural killer cell activity and activation by interleukin-2 and IFN-α Cell. Immunol. 155:1994;195-204.
14. Lebow L., Stewart C., Perelson A., Bonavida B. Analysis of lymphocyte-target conjugates by flow cytometry. I. Discrimination between killer and non-killer lymphocytes bound to targets and sorting of conjugates containing one or multiple lymphocytes. Nat. Immun. Cell Growth Reg. 5:1986;221-237.
15. Makinodan T., Kay M.M.B. Age influence on the immune system. Adv. Immunol. 29:1980;287-330.
16. Maria R.D., Cifone M.G., Trotta R., Rippo M.R., Festuccia C., Santoni A., Testi R. Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J. Exp. Med. 180:1994;1999-2004.
17. Markovic S.N., Murasko D.M. Neoadjuvant immunotherapy with interferon of the spontaneously metastasizing murine B16F10L melanoma. Int. J. Cancer. 77:1990;788-794.
18. Markovic S.N., Murasko D.M. Role of natural killer and T-cells in interferon induced inhibition of spontaneous metastases of the B16F10L murine melanoma. Cancer Res. 51:1991;1124-1128.
19. Martin S.J., Reutelingsperger C.P.M., McGahon A.J., Rader J.A., van Schie R.C.A.A., LaFace D.M., Green D.R. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182:1995;1545-1556.
20. Miller R.A. The aging immune system:primer and prospectus. Science. 273:1996;70-74.
21. Munker R, Marini F., Jiang S., Savary C., Owen-Schaub L., Andreef M. Expression of CD95 (Fas) by gene transfer does not sensitize K562 to Fas-killing. Hematol. Cell Ther. 39:1997;75-78.
22. Murasko D.M., Goonewardene I.M. T-cell function in aging: mechanisms of decline. Ann. Rev. Geriat. 10:1990;71-96.
23. Ortaldo J.R., Mason A.T., O'Shea J.J. Receptor-induced death in human natural killer cells: involvement of CD16. J. Exp. Med. 181:1995;339-344.
24. Plett A., Murasko D.M. Genetic differences in age-associated decrease in inducibility of natural killer cells by interferon-α/β Mech. Ageing Dev. 112:2000;197-215.
25. Provinciali M., Muzzioli M., Fabris N. Timing of appearance and disappearance of IFN and IL-2 induced natural immunity during ontogenetic development and aging. Exp. Gerontol. 24:1989;227-236.
26. Provinciali M., Fabris N., Pieri C. Improvement of natural killer cell activity by in vitro active lipid (AL 721) administration in old mice. Mech. Ageing Dev. 52:1990;245-254.
27. Rivnay B., Bergman B., Shinitzky M., Globerson A. Correlation between membrane viscosity, cholesterol, lymphocyte activation and aging in man. Mech. Ageing Dev. 12:1980;119-124.
28. Ross M.E., Caligiuri M.A. Cytokine-induced apoptosis of human natural killer cells indentifies a novel mechanism to regulate the innate immune response. Blood. 89:1997;910-918.
29. Shenoy A.M., Sidner R.A., Brahmi Z. Signal transduction in cytotoxic lymphocytes: decreased calcium influx in NK cell inactivated with sensitive target cells. Cell. Immunol. 147:1993;294-301.
30. Shinkai Y., Ishikawa H., Hattori M., Okumura K. Resistance of mouse cytolytic cells to pore-forming protein-mediated cytolysis. Eur. J. Immunol. 18:1988;29-35.
31. Slee E.A., Zhu H., Chow S.C., MacFarlane M., Nicholson D.W., Cohen G.M. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem. J. 315:1996;21-24.
32. Taga K., Yamauchi A., Kabashima K., Bloom E.T., Muller J., Tosato G. Target-induced death by apoptosis in human lymphokine-activated natural killer cells. Blood. 87:1996;2411-2418.
33. Verret C., Firmenich A., Kranz D., Eisen H. Resistance of cytotoxic T lymphocytes to the lytic effects of their toxic granules. J. Exp. Med. 166:1987;1536-1540.
34. Zola H., Neoh S.H., Mantzioris B.X., Webster J., Loughnan M.S. Detection by immunofluorescence of surface molecules present in low copy numbers. High sensitivity staining and calibration of flow cytometer. J. Immunol. Meth. 135:1990;247-255.